AGEN Competitors & Alternatives
Compare Agenus Inc with similar stocks in the same industry
Biotechnology
AGEN
Main Stock$7.94
Tradestie Score
50
Market Cap
$124.27M
P/E Ratio
3.7
Revenue Growth
0.4%
Analyst Upside
+177.1%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ALT
Altimmune, Inc. Common Stock
|
$2.99
|
$341.56M | - | 52 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$5.35
|
$332.96M | - | 49 | Compare |
|
REPL
Replimune Group, Inc.
|
$11.85
|
$328.62M | - | 50 | Compare |
|
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
|
$15.90
|
$308.74M | - | 56 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$10.29
|
$304.12M | - | 52 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$20.21
|
$297.23M | - | 52 | Compare |
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$28.64
|
$293.03M | - | 50 | Compare |
|
OMER
Omeros Corporation
|
$12.59
|
$281.75M | 10.4 | 63 | Compare |
|
DBVT
DBV Technologies S.A.
|
$13.62
|
$275.54M | - | 43 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$1.88
|
$275.13M | - | 48 | Compare |
More AGEN Analysis
Data updated: Aug 04, 2026 | Industry: Biotechnology (SIC 2836)
230 stocks in this industry